ZELBORAF is a prescription medicine used to treat: 1. a type of skin cancer called melanoma that: o has spread to other parts of the body or cannot be removed by surgery, and o has a certain type of abnormal “BRAF” gene. and 2. a type of blood cell cancer called Erdheim-Chester Disease (ECD) that: o can affect body tissues and organs, and o has a certain type of abnormal “BRAF” gene. Zelboraf (vemurafenib) was first approved August 17, 2011)
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of ZELBORAF (vemurafenib) Tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ZELBORAF (vemurafenib) Tablets tablets cost price in India.
The order for ZELBORAF (vemurafenib) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Vemurafenib (INN, marketed as Zelboraf) is an inhibitor of the B-Raf enzyme developed by Plexxikon (now part of Daiichi-Sankyo) and Genentech for the treatment of late-stage melanoma. The name "vemurafenib" comes from V600E mutated BRAF inhibition.
ZELBORAF (vemurafenib) Tablets tablets, for oral use. Initial U.S. Approval: 2011
Generic Name: vemurafenib
Tablet: 240 mg.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ZELBORAF (vemurafenib) Tablets on prescription and Import License in Patient's Name only.
For overseas patients, ZELBORAF (vemurafenib) Tablets can be made available in Send your enquiry to find ZELBORAF (vemurafenib) Tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For ZELBORAF (vemurafenib) Tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Cobimetinib/Vemurafenib OS Benefit Sustained at 5 Years in BRAF+ Melanoma For More Details
FDA expert panel unanimously recommends approval for Horizon Therapeutics eye drug For More Details